Norethindrone and Ethinyl Estradiol Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - June 20, 2018 Category: Drugs & Pharmacology Source Type: news

New study suggests ovarian hormone may make drug withdrawal symptoms worse for women
(Dickinson College) Researchers found that a form of the estrogen hormone can contribute to drug relapse in females by worsening withdrawal symptoms. The study looked at the interaction of the female sex hormone estradiol and methamphetamine. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 18, 2018 Category: International Medicine & Public Health Source Type: news

Testosterone May Be Key to CVD Risk in Women Testosterone May Be Key to CVD Risk in Women
A new analysis shows that higher testosterone levels and a higher ratio of testosterone to estradiol in postmenopausal women are associated with higher risk for cardiovascular disease.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 14, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Does stabilizing female hormones help lower suicide risk?
(University of Illinois at Chicago) A three-year, $750,000 grant from the National Institutes of Mental Health will help researchers determine whether the stabilization of ovarian hormones estradiol and progesterone can help lower symptoms associated with suicidality among females at risk for suicide. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 4, 2018 Category: International Medicine & Public Health Source Type: news

Oral Semaglutide Success; Lowest-Dose Vaginal Estradiol OK'd
(MedPage Today) -- News and commentary from the endocrinology world (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - June 1, 2018 Category: Urology & Nephrology Source Type: news

Postmenopausal Sex Hormone Levels Associated With Later CVD
FRIDAY, June 1, 2018 -- In postmenopausal women, higher testosterone/estradiol ratios are associated with increased risks for incident cardiovascular disease (CVD), coronary heart disease (CHD), and heart failure events, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 1, 2018 Category: Pharmaceuticals Source Type: news

FDA Approves Imvexxy for Moderate to Severe Dyspareunia FDA Approves Imvexxy for Moderate to Severe Dyspareunia
The FDA approved estradiol vaginal inserts (Imvexxy, TherapeuticsMD) for moderate to severe dyspareunia.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 31, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Alert Source Type: news

Hormone therapy may slow cognitive decline
A combination therapy of estradiol and progesterone may benefit cognitive function in postmenopausal women, a study inMenopause suggests.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - May 31, 2018 Category: Endocrinology Source Type: news

TherapeuticsMD Announces FDA Approval of Imvexxy (estradiol vaginal inserts) for the Treatment of Dyspareunia Due to Menopause
BOCA RATON, Fla., May 30, 2018 /PRNewswire/ -- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women ' s healthcare company, today announced that the United States Food and Drug Administration (FDA) has approved Imvexxy (estradiol vaginal inserts)... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 31, 2018 Category: Drugs & Pharmacology Source Type: news

On second try, TherapeuticsMD lands FDA nod for vaginal capsule
TherapeuticsMD (NSDQ:TXMD) said today that it won FDA approval for its applicator-free estradiol vaginal capsule, TX-004HR. The soft-gel capsule is designed to treat moderate-to-severe vaginal pain experienced during sex, a symptom of vulvar and vaginal atrophy in women who have undergone menopause. Get the full story at our sister site, Drug Delivery Business News. The post On second try, TherapeuticsMD lands FDA nod for vaginal capsule appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - May 30, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Food & Drug Administration (FDA) Pharmaceuticals Regulatory/Compliance Wall Street Beat Women's Health TherapeuticsMD Source Type: news

Hormone Levels After Menopause Tied to Heart Risks (CME/CE)
(MedPage Today) -- Higher testosterone/estradiol ratio associated with CVD, CHD, and HF (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - May 29, 2018 Category: Endocrinology Source Type: news

Allergan Issues Nationwide Voluntary Recall of TAYTULLA ® Softgel Capsules 1mg/20mcg Sample Packs Due to Out of Sequence Capsules
Allergan plc (NYSE:AGN) today issued a voluntary recall in the US market of one lot (Lot# 5620706, Expiry May-2019) of TAYTULLA ® (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) 1mg/20mcg, 6x28 physicians sample pack, indicated for use by women to prevent pregnancy. Allergan recently identified, through a physician report, that four placebo capsules were placed out of order in a sample p ack of TAYTULLA. Specifically, the first four days of therapy had four non-hormonal placebo capsules instead of active capsules. (Source: Food and Drug Administration)
Source: Food and Drug Administration - May 29, 2018 Category: Food Science Source Type: news

Allergan Issues Nationwide Voluntary Recall of TAYTULLA ® Softgel Capsules 1mg/20mcg Sample Packs Due to Out of Sequence Capsules
Allergan plc (NYSE:AGN) today issued a voluntary recall in the US market of one lot (Lot# 5620706, Expiry May-2019) of TAYTULLA ® (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules) 1mg/20mcg, 6x28 physicians sample pack, indicated for use by women to prevent pregnancy. Allergan recently identified, through a physician report, that four placebo capsules were placed out of order in a sample pack of TAYTULLA. Specifically, the first four days of therapy had four non-hormonal placebo capsules instead of active capsules. (Source: Food and Drug Administration)
Source: Food and Drug Administration - May 29, 2018 Category: Food Science Source Type: news

Osteoporosis Spinal Fractures; Vaginal Estradiol Tx; Diabetic Dog Lawsuit?
(MedPage Today) -- News and commentary from the endocrinology world (Source: MedPage Today OB/GYN)
Source: MedPage Today OB/GYN - May 11, 2018 Category: OBGYN Source Type: news

Low - Dose Vaginal Estradiol Improves Menopause - Linked QOL
Significant improvement in total MENQOL scores, MENQOL sexual function domain for vaginal estradiol (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - May 10, 2018 Category: Psychiatry Tags: Family Medicine, Gynecology, Internal Medicine, Pharmacy, Psychiatry, Journal, Source Type: news